FNY Investment Advisers LLC’s holdings in MiMedx Group were worth $225,000 at the end of the most recent quarter.

Source: https://www.etfdailynews.com/2023/09/17/fny-investment-advisers-llc-has-225000-stake-in-mimedx-group-inc-nasdaqmdxg/

G Medical Innovations has lower revenue, but higher earnings than MiMedx Group.

Source: https://www.dailypolitical.com/2023/06/24/analyzing-mimedx-group-nasdaqmdxg-and-g-medical-innovations-nasdaqgmvd.html

Goldman Sachs Group Inc. boosted its holdings in MiMedx Group by 40.7% in the 1st quarter.

Source: https://www.etfdailynews.com/2023/05/15/mimedx-group-inc-nasdaqmdxg-insider-robert-benjamin-stein-sells-5869-shares/

MiMedx Group (NASDAQ:MDXG) was downgraded by analysts at from a strong-buy rating to a buy rating.

Source: https://www.dailypolitical.com/2023/03/31/analysts-downgrades-for-march-31st-abcb-acn-banr-bbva-cubi-fc-fnwb-hpe-hsic-mdxg.html

TheStreet upgraded MiMedx Group from a “d” rating to a “c-” rating in a research report on Wednesday, August 2nd.

Source: https://www.etfdailynews.com/2023/09/17/fny-investment-advisers-llc-has-225000-stake-in-mimedx-group-inc-nasdaqmdxg/